On 29 September, Suzhou Novoprotein Scientific Co., Ltd. was listed on the STAR Market. The stock name is Novoprotein, the stock code is 688137. SH, with the issue price is 106.19 CNY / share, which broke after the opening, with a market capitalization of over CNY 5.6 billion.

Established in September 2009, Novoprotein is a high-tech enterprise focusing on protein technology and application solutions. Its main business is the development, production and sales of raw materials and technology solutions for biopharmaceuticals, in vitro diagnostics, mRNA vaccine drugs and basic life science research, including target and factor-based proteins, recombinant antibodies, enzymes and reagents and related technical services.

From 2019 to 2021, the revenue from the main business of Novoprotein will be CNY 35,574.3 million, CNY 180 million and CNY 342 million, respectively. 2020 and 2021 will be substantially higher than the previous year, with an increase of 405.23% and 90.16%, respectively, reflecting the strong competitive advantage of the Company.

Novoprotein has experience in the development of tens of thousands of recombinant proteins. We believe that with the support of capital power, Novoprotein will continue to focus on innovation in research and development technology in the future, and provide customers with a full range of services based on a more complete technical system and innovative raw materials produced in-house.